F]FDG PET/CT for comprehensive assessment of disease extent and rapid metastatic progression in this rare malignancy.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: